DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI

June 20, 2023

TORONTO, June 20, 2023 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB:DGNMF), a generative artificial intelligence (“AI”) healthcare company, is pleased to announce an update of CERVAI™, the Company’s proprietary AI brain health platform. CERVAI™ is a brain health AI platform leveraging generative AI that aims to estimate and monitor brain age and provide actionable insights and tools to diagnose, prevent or improve cognitive decline while providing actionable risk assessments for brain health through web and mobile applications.

Read more at globenewswire.com

Related news for (DGNMF)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.